Fulvestrant Run-In Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: Abemaciclib, Fulvestrant

Pipeline

Phase 2: 1

Top Sponsors

The Methodist Hospital Research Institute1

Indications

ER-positive Breast Cancer1
HER2-negative Breast Cancer1
Breast Cancer1
Cancer1

Houston, Texas1 trial

Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

Houston Methodist Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.